Simplex Trading’s Eiger BioPharmaceuticals EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-80
Closed -$2K – 10231
2023
Q1
$2K Buy
80
+20
+33% +$930 ﹤0.01% 8580
2022
Q4
$2K Sell
60
-80
-57% -$9.6K ﹤0.01% 8699
2022
Q3
$31K Buy
140
+133
+1,900% +$32.7K ﹤0.01% 7050
2022
Q2
$1K Sell
7
-173
-96% -$34.9K ﹤0.01% 9739
2022
Q1
$44K Buy
+180
New +$28.4K ﹤0.01% 7326
2021
Q4
– Sell
-483
Closed -$126K – 11691
2021
Q3
$126K Hold
483
– – ﹤0.01% 6292
2021
Q2
$123K Buy
483
+481
+24,050% +$120K ﹤0.01% 6438
2021
Q1
$55K Buy
+2
New +$630 ﹤0.01% 6503
2020
Q4
– Hold
0
– – – 7376
2020
Q3
– Hold
0
– – – 6924
2016
Q1
– Hold
0
– -$7K – 6407
2015
Q4
– Hold
0
– – – 3660
2015
Q3
– Sell
-1
Closed -$530 – 2664
2015
Q2
$201K Hold
1
– – 0.02% 794
2015
Q1
$148K Buy
+1
New +$8.74K 0.02% 860

Other funds holding EIGR

Simplex Trading's EIGR Position: Q1 2024 in Review

Simplex Trading sold out of Eiger BioPharmaceuticals (EIGR) in Q1 2024, closing a stake of 437 shares — an estimated $2K sold.

Simplex Trading first reported a position in EIGR in Q1 2015 and held it in 13 quarters. The position peaked at $532K in Q1 2022. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

  • Simplex Trading reported no remaining Eiger BioPharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 437 Eiger BioPharmaceuticals shares in Q1 2024, an estimated $2K.
  • Simplex Trading first reported a position in Eiger BioPharmaceuticals in Q1 2015 and held it in 13 quarters.
  • Simplex Trading's Eiger BioPharmaceuticals position peaked at $532K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.